François-Clément Bidard Selected Research

François-Clément Bidard Research Topics

Disease

37	Neoplasms (Cancer) 11/2022 - 03/2008
25	Breast Neoplasms (Breast Cancer) 04/2022 - 01/2008
12	Circulating Neoplastic Cells 04/2022 - 11/2008
8	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2008
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2020 - 08/2017
4	Uveal melanoma 01/2018 - 07/2012
3	COVID-19 04/2021 - 01/2020
3	Disease Progression 01/2021 - 04/2011
3	Colorectal Neoplasms (Colorectal Cancer) 12/2019 - 05/2012
3	Lung Neoplasms (Lung Cancer) 01/2019 - 02/2012
3	Triple Negative Breast Neoplasms 01/2016 - 01/2015
3	Inflammatory Breast Neoplasms 01/2016 - 04/2012
2	Microsatellite Instability 01/2020 - 10/2018
2	Lymphatic Metastasis 01/2016 - 01/2015
1	Adenocarcinoma 07/2021
1	Respiratory Insufficiency (Respiratory Failure) 04/2021
1	Ageusia (Hypogeusia) 01/2021
1	Anosmia 01/2021
1	Rare Diseases (Rare Disease) 04/2020
1	Pneumonia (Pneumonitis) 01/2020
1	Endometrial Neoplasms (Endometrial Cancer) 01/2020
1	Spinal Cord Diseases 11/2019
1	Myelitis 11/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2019
1	Carcinoma (Carcinomatosis) 04/2019
1	Sarcoma (Soft Tissue Sarcoma) 01/2019
1	Meningeal Carcinomatosis 01/2017
1	Melanoma (Melanoma, Malignant) 03/2016
1	Thrombotic Microangiopathies 01/2016
1	Pathologic Complete Response 03/2015
1	Vascular Remodeling 02/2015
1	Disseminated Intravascular Coagulation 06/2014
1	Hypertension (High Blood Pressure) 04/2012

Drug/Important Bio-Agent (IBA)

15	Biomarkers (Surrogate Marker)IBA 04/2022 - 11/2008
10	Circulating Tumor DNAIBA 09/2021 - 07/2012
6	Bevacizumab (Avastin)FDA Link 01/2021 - 04/2012
5	Hormones (Hormone)IBA 01/2021 - 11/2008
4	Estrogen ReceptorsIBA 07/2022 - 01/2020
4	Pharmaceutical PreparationsIBA 11/2019 - 03/2014
3	Biological ProductsIBA 01/2021 - 11/2009
3	Tumor Biomarkers (Tumor Markers)IBA 01/2020 - 02/2012
3	Trastuzumab (Herceptin)FDA Link 11/2018 - 04/2012
3	AntigensIBA 04/2014 - 02/2012
2	Phenobarbital (Luminal)FDA Link 11/2022 - 01/2021
2	RNA (Ribonucleic Acid)IBA 10/2021 - 01/2020
2	palbociclibIBA 01/2021 - 01/2020
2	Fluorouracil (Carac)FDA LinkGeneric 04/2020 - 08/2017
2	Docetaxel (Taxotere)FDA Link 04/2020 - 08/2017
2	Cisplatin (Platino)FDA LinkGeneric 04/2020 - 08/2017
2	Oxygen (Dioxygen)IBA 01/2020 - 06/2015
2	Immune Checkpoint InhibitorsIBA 11/2019 - 01/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2016 - 06/2015
2	DNA (Deoxyribonucleic Acid)IBA 04/2015 - 07/2012
2	Carcinoembryonic AntigenIBA 04/2014 - 02/2012
1	Radioisotopes (Radionuclides)IBA 11/2022
1	Proteins (Proteins, Gene)FDA Link 04/2022
1	MucinsIBA 07/2021
1	N-(2-naphthalene)sulfonyl-DL-tryptophan (A 91)IBA 01/2021
1	dimemorfan (AT 17)IBA 01/2021
1	Fulvestrant (Faslodex)FDA Link 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	atezolizumabIBA 04/2020
1	Aromatase InhibitorsIBA 04/2020
1	human ERBB2 proteinIBA 04/2020
1	Tamoxifen FDA LinkGeneric 04/2020
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2020
1	N(1)- pentadecanoyl- N(3'')- trifluoracetylkanamycin AIBA 01/2020
1	thymidine kinase 1IBA 01/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020
1	LigandsIBA 01/2020
1	Viral RNAIBA 01/2020
1	pembrolizumabIBA 11/2019
1	AfatinibIBA 11/2018
1	Lapatinib (GW572016)FDA Link 11/2018
1	ParaffinIBA 01/2018
1	Formaldehyde (Formol)FDA Link 01/2018
1	cadherin 5IBA 01/2017
1	osimertinibIBA 01/2017
1	cyclo(Arg-Pro) (CI 4)IBA 11/2016
1	Temozolomide (Temodar)FDA LinkGeneric 03/2016
1	Angiogenesis InhibitorsIBA 06/2015
1	Endothelial Growth FactorsIBA 06/2015
1	AntibodiesIBA 02/2015
1	FSH Receptors (FSH Receptor)IBA 02/2015
1	Dacarbazine (DIC)FDA LinkGeneric 06/2014
1	Immunoconjugates (Immunoconjugate)IBA 03/2014
1	Monoclonal AntibodiesIBA 03/2014
1	antigen CYFRA21.1IBA 02/2012
1	Lactic Acid (Lactate)FDA LinkGeneric 02/2012

Therapy/Procedure

22	Therapeutics 04/2022 - 06/2013
14	Drug Therapy (Chemotherapy) 09/2021 - 11/2008
8	Neoadjuvant Therapy 01/2021 - 11/2008
3	Immunotherapy 01/2020 - 10/2018
2	Radiotherapy 01/2020 - 11/2019
1	Terminal Care (Care, Terminal) 04/2021
1	Resuscitation 04/2021
1	Palliative Care (Palliative Therapy) 04/2021
1	Chemoradiotherapy 11/2018
1	Adjuvant Chemotherapy 01/2016
1	Precision Medicine 04/2015